Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
Authors
Keywords
-
Journal
ALLERGY
Volume 71, Issue 9, Pages 1335-1344
Publisher
Wiley
Online
2016-04-18
DOI
10.1111/all.12914
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute and chronic systemic corticosteroid–related complications in patients with severe asthma
- (2015) Patrick Lefebvre et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma
- (2015) Hector Ortega et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- An update on emerging drugs for asthma
- (2012) Garry M Walsh EXPERT OPINION ON EMERGING DRUGS
- Characterization of Asthma Exacerbations in Primary Care Using Cluster Analysis
- (2012) Hector Ortega et al. JOURNAL OF ASTHMA
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Asthma phenotypes: the evolution from clinical to molecular approaches
- (2012) Sally E Wenzel NATURE MEDICINE
- Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma
- (2011) J. Bousquet et al. ALLERGY
- The who, where, and when of IgE in allergic airway disease
- (2011) Melissa Dullaers et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
- (2010) L. G. Heaney et al. THORAX
- Relationship between pretreatment specific IgE and the response to omalizumab therapy
- (2009) U. Wahn et al. ALLERGY
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
- (2009) Prescott G. Woodruff et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-5- and eosinophil-mediated inflammation: from discovery to therapy
- (2009) T. Kouro et al. INTERNATIONAL IMMUNOLOGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now